Drug Discovery for the Treatment of Addiction (eBook)
368 Seiten
John Wiley & Sons (Verlag)
978-1-118-88959-6 (ISBN)
fills an important and timely need for medicinal chemists who need
to understand complex neuroscience issues. The author illustrates
medicinal chemistry's prominent role in treating addiction and
covers specific drugs of abuse including narcotics, stimulants,
depressants, nicotine, and marijuana.
* Interprets complex neuro- biological and
pharmacological information, like the drug-reward system, for
medicinal chemists
* Emphasizes neurotransmitters and neurochemical
mechanisms of addictive drugs
* Pulls together information on the many potential drug
targets for treating addiction
* Stresses unique medicinal chemistry problems when
describing pharmacology testing methods and drug development
Brian S. Fulton is a Visiting Lecturer in the Department of Chemistry and Chemical Biology at Northeastern University and has taught courses in organic chemistry, spectroscopy, and pharmaceutical sciences and has taught a one-semester course, Medicinal Chemistry of Psychiatric Drugs, at Harvard University Extension School. From 1987 - 2005, Dr. Fulton worked as an industrial organic chemist in the US and Europe. He obtained his B.S. in Chemistry at Missouri State University and his Ph.D. in Organic Chemistry at Iowa State University. He has written 17 peer-reviewed publications and given 8 presentations at scientific meetings.
Preface xiii
1 What Is Drug Addiction? 1
1.1 Definitions 2
1.2 The Drugs of Abuse 4
1.3 Schedule of Controlled Substances 5
1.4 Some Facts From 2012 NSDUH Study 6
1.5 The Addictive State 8
1.6 Theories of Addiction 12
1.7 Comorbidity 13
1.8 Genetic Aspects of Addiction 13
1.9 Approved Medications for the Treatment of Substance Abuse
and Addiction 16
2 Physiological Basis of Addiction--A Chemist's
Interpretation 18
2.1 The Reward System 19
2.2 Neuroanatomy of the Reward System 21
2.3 Brief Review of the Central Nervous System and Addiction
22
2.4 Neurotransmitters and Their Targets 25
2.5 Neurocircuitry and Neurotransmitters in Addiction 32
2.6 Location of Receptors 62
2.7 An Example 64
2.8 Use of Biological Markers 65
2.9 Memories and Addiction 68
2.10 Stress the HPA Axis and Addiction 72
3 Behavioral Pharmacology and Addiction 76
3.1 Animal Models of Addiction 76
3.2 Self-Administration 80
3.3 Conditioned Place Preference 85
3.4 Tolerance 86
3.5 Extinction/Withdrawal 87
3.6 Reinstatement (Animal Models of Relapse) 87
3.7 Drug Discrimination 89
3.8 Operant Sensation Seeking Model 92
3.9 Use of Animal Behavioral Models 92
Acknowledgments 93
4 Medication Development for the Treatment of Drug Addiction
94
4.1 Lead Discovery 95
4.1.1 NIDA Addiction Treatment Discovery Program 96
4.2 Pharmacological Assays 103
4.3 Partial Agonist Approach 110
4.4 Allosteric Modulators 110
4.5 Functional Interactions Between Receptors 114
4.6 Multi-Target Drugs 121
4.7 Physicochemical Properties of CNS Drugs and Blood-Brain
Barrier 124
4.8 Brain Imaging Agents 131
4.9 QT Prolongation 135
5 Medication Development for Narcotic Addiction 137
5.1 Pharmacology of Narcotic Addiction and Pain 138
5.2 Prescription Drug Addiction 139
5.3 Approved Medications 140
5.4 Medication Development 151
6 Medication Development for Stimulant Addiction 160
6.1 Pharmacology of Cocaine Addiction 160
6.2 Pharmacology of Methamphetamine Addiction 163
6.3 Medication Development 166
7 Medication Development for Depressant Addiction 213
7.1 Pharmacology of Alcohol Addiction 213
7.2 Approved Medications 214
7.3 Medication Development 219
7.4 Benzodiazepines 228
7.5 Barbiturates 229
8 Medication Development for Nicotine Addiction 230
8.1 Pharmacology of Nicotine Addiction 230
8.2 Approved Medications 232
8.3 Medication Development 237
9 Medication Development for Marijuana Addiction 240
9.1 Pharmacology of Marijuana Addiction 241
9.2 CB1 Antagonist: Rimonabant 243
9.3 Medication Development 244
10 Designer Drugs 252
10.1 Cathinone Drugs 253
10.2 MDMA--ECSTASY 256
10.3 Cannabinoid Designer Drugs 257
Conclusion 259
Appendix A Further Reading for Chemists Interested in a More
Detailed Understanding of Addiction and the Central Nervous System
261
Appendix B Public Databases and Sources of Information of
Interest to Medicinal Chemistry Addiction Researchers 262
Appendix C Glossary of Terms Used in Addiction Research 263
Appendix D Glossary of Terms Used in Medicinal Chemistry 271
References 290
Index 335
Erscheint lt. Verlag | 29.7.2014 |
---|---|
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
Naturwissenschaften ► Biologie | |
Naturwissenschaften ► Chemie | |
Technik | |
Schlagworte | Biowissenschaften • Chemie • Chemistry • Drug Discovery & Development • Life Sciences • Medical Science • Medizin • Medizinische Chemie • Neuroscience • Neurowissenschaften • Pharmacology & Pharmaceutical Medicine • Pharmakologie u. Pharmazeutische Medizin • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung |
ISBN-10 | 1-118-88959-2 / 1118889592 |
ISBN-13 | 978-1-118-88959-6 / 9781118889596 |
Haben Sie eine Frage zum Produkt? |
Größe: 11,2 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich